OP7H:PA:PA-Ossiam Bloomberg USA PAB UCITS ETF - 1A EUR Hedged Acc (EUR)

ETF | Others |

Last Closing

USD 127.5087

Change

+2.82 (+2.26)%

Market Cap

N/A

Volume

238.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.18 (-0.41%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+2.95 (+0.62%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+2.03 (+0.59%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

+0.19 (+0.59%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.91 (+0.37%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+4.00 (+0.98%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.68 (+0.54%)

USD 7.49B
HHH:PA HSBC S&P 500 UCITS ETF

+0.31 (+0.65%)

USD 7.22B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.06 (-0.97%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.07 (-0.09%)

USD 5.38B

ETFs Containing OP7H:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.36% 31% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.36% 30% F 34% F
Trailing 12 Months  
Capital Gain 7.66% 80% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.66% 78% C+ 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.00% 56% F 64% D
Dividend Return 9.00% 57% F 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.74% 55% F 77% C+
Risk Adjusted Return 76.71% 57% F 75% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike